HSD3B1 and posterior cortical atrophy: The HSD3B1 CA genotype showed a non-significant trend toward increased PCa risk (OR = 2.39, p = 0.183, 95% CI: 0.66–8.61) that requires validation in larger studies before any clinical relevance can be established.